David L. Paterson

Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity

D. Paterson, A. Cheng, B. Rogers, 2011, Internal medicine journal.

Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

A. Farcomeni, R. Bonomo, Y. Carmeli, 2018, International journal of antimicrobial agents.

Vancomycin therapeutics and monitoring: a contemporary approach

V. Vaska, M. Avent, S. V. Hal, 2013, Internal medicine journal.

Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in Turkey

D. Paterson, M. Akova, J. Perry, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Return to sender: the need to re‐address patient antibiotic allergy labels in Australia and New Zealand

K. Urbancic, David L. Paterson, Leon J. Worth, 2016, Internal medicine journal.

Ceftizoxime, cefdinir, cefditoren, cefpodoxime, ceftibuten, cefsulodin, and cefpiramide

David L. Paterson, Mesut Yilmaz, 2017 .